Last updated on December 2018

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Primary Sjogren's Syndrome
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Fulfilled revised American European Consensus Group criteria for pSS
  • Seropositive at screening for anti-Ro/SSA antibodies
  • Screening ESSDAI value >=6 scored from 7 domains: articular, cutaneous, glandular, lymphoadenopathy, constitutional, biologic and hematologic.

Exclusion Criteria:

  • Secondary Sjogren's syndrome
  • Use of other investigational drugs
  • Active viral, bacterial or other infections
  • Positive hepatitis B, hepatitis C, HIV or tuberculosis test results at screening

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.